Regions Financial Corp Alaunos Therapeutics, Inc. Transaction History

Regions Financial Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 19, 2019	SELL	$3.98 - $6.2 $644 - $1,004	-162 Closed	0 $0
Q1 2019 Apr 19, 2019	BUY	$2.0 - $4.4 $324 - $712	162 New	162 $1,000
Q1 2018 Apr 18, 2018	SELL	$3.46 - $5.14 $1,730 - $2,570	-500 Closed	0 $0
Q4 2017 Jan 18, 2018	BUY	$4.0 - $6.54 $2,000 - $3,270	500	500 $2,000

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $443M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Regions Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Regions Financial Corp with notifications on news.